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Abstract
Background: Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus, leading to an acute encephalitis and
damage to the central nervous system (CNS). The mechanism of JEV pathogenesis is still unclear. DNA microarray
analyses have been recently employed to detect changes in host gene expression, which is helpful to reveal
molecular pathways that govern viral pathogenesis. In order to globally identify candidate host genes associated
with JEV pathogenesis, a systematic mRNA profiling was performed in spleens and brains of JEV-infected mice.
Results: The results of microarray analysis showed that 437 genes in spleen and 1119 genes in brain were
differentially expressed in response to JEV infection, with obviously upregulated genes like pro-inflammatory
chemokines and cytokines, apoptosis-related proteases and IFN inducible transcription factors. And the significant
pathways of differentially expressed genes are involved in cytokine-cytokine receptor interaction, natural killer cell
mediated cytotoxicity, antigen processing and presentation, MAPK signaling, and toll-like receptor signaling, etc.
The differential expression of these genes suggests a strong antiviral response of host but may also contribute to
the pathogenesis of JEV resulting in encephalitis. Quantitative RT-PCR (RT-qPCR) assay of some selected genes
further confirmed the results of microarray assay.
Conclusions: Data obtained from mRNA microarray suggests that JEV infection causes significant changes of
mRNA expression profiles in mouse spleen and brain. Most of differentially expression genes are associated with
antiviral response of host, which may provide important information for investigation of JEV pathogenesis and
therapeutic method.
Background
Japanese encephalitis virus (JEV), a mosquito-borne fla-
vivirus belonging to family Flaviviridae,i sr e s p o n s i b l e
for an acute encephalitis and damage to the central ner-
vous system (CNS) in wide areas of southern and east-
ern Asia. And recently, it has been isolated from
previously non-affected areas, such as Australia [1].
Japanese encephalitis (JE) has a high fatality rate of 30%
and around half of the JE survivors have severe neurolo-
gical sequelae [2]. Approximately 50,000 JE cases with
10,000 deaths are reported annually [3]. Following entry
into the host system through a mosquito bite, JEV may
replicates in various organs such as liver and spleen, and
then reaches the central nervous system, resulting in a
rapid inflammatory response [4]. According to the
observations from studies of other flaviviruses, specifi-
cally dengue virus, it has been proposed that JEV tra-
verse through a lymphatic route that also involves cells
of the monocyte/macrophage lineage. Recently, JEV has
been shown to effectively replicate within lymphocytes
and macrophages, thereby making these cell types possi-
ble carriers of the virus from the periphery to the CNS
[5,6]. However, it remains to be elucidated how JEV
infects the CNS via these peripheral cells. In addition,
although neurological disorders caused by JEV are often
characterized by evidence of immune system recognition
and the presence of inflammatory components among
the neuropathological changes, the mechanisms by
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understood [7].
Recently, multiple DNA microarray analyses have been
employed to detect changes in host gene expression
after viral infection, which makes it possible to reveal
molecular pathways that govern viral pathogenesis. Gen-
echip analysis of human umbilical vein endothelial cells
infected with Dengue Virus (DV) detected the upregula-
tion of 269 genes and downregulation of 126 genes [8].
Gene profiling study of West Nile Virus (WNV) infected
human embryonic kidney cells, human glioma cells and
mice tissues were also performed [9,10]. Furthermore,
identification of gene profiles in JEV-infected neuroblas-
toma cells and brain tissue have been reported recently,
suggesting an increased expression of pro-inflammatory
cytokines, chemokines, and anti-viral response genes
after JEV infection [11,12]. However, both of studies on
JEV were restricted to CNS, and few gene profiling
researches about response in peripheral immune system
has been carried out.
In present study, to globally identify candidate host
genes associated with JEV pathogenesis, DNA microar-
ray technology was utilized to investigate mRNA profile
in spleen and brain tissues of mice infected with JEV
wild strain P3, and some of the selected genes were
further confirmed by quantitative RT-PCR. It was
demonstrated that JEV infection resulted in significant
changes in the expression of numerous genes in spleen
and brain tissues, which could be crucial messages for
revealing of JEV pathogenesis.
Results
mRNA expression profile of JEV-infected mice
A mouse whole gene array was used to perform a sys-
tematic analysis of mRNA expression profile of spleen
and brain tissues of JEV P3-infected mice which were
sacrificed at day 3 and day 6 post-inoculation respec-
tively. Genes that had ≥ |2|-fold change were identified
as significantly differential expression. Of 41174 genes
represented on the chip, 437 genes were differentially
expressed in mouse spleens and 1119 genes were differ-
entially regulated in brains in response to JEV infection
(change fold ≥ 2.0, p value < 0.05). Unsupervised clus-
tering (Figure 1) analysis of the expression profiles
showed a distinct mRNA signature in both spleens and
brains during JEV infection. To elucidate the correlation
between gene expression pattern and JEV infection-
induced biological processes, functional classification of
mRNA transcripts and pathw a ya n a l y s i sw e r ep e r -
formed. Differentially regulated genes in spleens of JEV-
infected mice are involved in the biological processes
such as cellular process, biological regulation and
immune system process, etc (Figure 2A). And the signif-
icant pathways of differentially expressed genes are
known to be involved in cytokine-cytokine receptor
interaction, natural killer cell mediated cytotoxicity, anti-
gen processing and presentation, and chemokine signal-
ing, etc (Table 1). While biological processes which
showed differentially regulated genes in brains of JEV
infected mice are cellular process, metabolic process,
and biological regulation, etc (Figure 2B). And the sig-
nificant pathways of differentially expressed genes in
mouse brain are cytokine-cytokine receptor interaction,
MAPK signaling, neuroactive ligand-receptor interac-
tion, and toll-like receptor signaling, etc. (Table 2).
Genes with differential expression in spleens of JEV-
infected mice
In spleens of mice with JEV infection, 263 genes were
detected to be significantly upregulated and 174 genes
were downregulated (Table 3). Genes with increased
expression in spleens of JEV infected mice mainly fell
into the function of immune response to viral infections.
These include pro-inflammatory cytokine IFN-g,I F N
response transcription factor IRF7, IFN-induced proteins
like IFIT1, IFITM3 and IFITM7, protein degradation
gene ubiquitin-specific protease Usp29 and Usp18,
apoptosis related genes granzymA, granzymeB, Porferin,
and IMNB2, killer cell lectin-like receptors KLRC1,
KLRC2 and KLRC3, and chemokines such as CXCL10,
CXCL11, CCL12, CCL2 and CCL9. The marked
increase in expression of these genes implies the occur-
rence of a strong antiviral protective response to JEV
infection. The significantly downregulated genes are
mainly involved in cell adhesion molecules such as
monocyte/macrophage-lineage cell marker CD163,
transmembrane cell surface receptor of Langerhans cells
CD207, and ligand for myeloid cells receptor CD200.
Evidence was also found for decreased expression of
interferon transcription factor IRF6 and interleukin 7
receptor, which may contribute to JEV pathogenesis as
well.
Genes with differential expression in brains of JEV-
infected mice
Compared to the expression after mock infection, 551
genes were detected to be significantly upregulated and
568 genes were downregulated in brains of JEV-infected
mice (Table 4). Consistent to the results of spleen, che-
mokines CCL2, CCL3, CCL4 and CXCL10, IFN
response transcription factor IRF7, IFN-induced proteins
like Ifit1, Ifit2 and Ifit3, protein degradation gene Usp18
were obviously upregulated, and CD163 and IRF6
showed decreased expression upon JEV infection. In
addition, increased expression of IFN-inducible tran-
scription factors STAT1 and STAT2, TNF-a induced
protein TNFAIP3, apoptosis-related proteins caspase3
and caspase4, suppressors of cytokine signaling Socs1
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T L R 7 ,a sw e l la sI F Nr e s p o n se antiviral genes of OAS
family were also observed in microarray analysis. These
results suggested the occurrence of a strong inflamma-
tory response in mouse brain.
Confirmation of microarray data by RT-qPCR
To confirm the microarray hybridization results, quanti-
tative RT-PCR was performed on eight selected differen-
tially expressed mRNAs in mouse spleen and brain
respectively. As shown in the RT-qPCR result of spleen,
granzymA, granzymeB, Porferin, IRF7, IFN-g,C X C L 1 0 ,
and ILIR2 were significantly upregulated, while CD163
was downregulated (Table 5). Out of eight tested
mRNAs in brains of mice infected with JEV, CCL2,
CCL4, CXCL10, Casp3, Casp4, SOCS1 and SOCS3
showed increased expression, and CD163 was also found
to have an obviously decreased expression (Table 5).
Although absolute values are not identical due to the dif-
ferent sensitivity between the techniques, all genes
(A)                                                  (B) 
Figure 1 Unsupervised hierarchical clustering of differentially expressed mRNAs. mRNA hybridization was performed with the use of 4 ×
44 K Agilent Whole Mouse Genome Oligo Microarray. For each sample pair, the experiments were done with two independent hybridizations
(Cy3 and Cy5 interchanging labeling). Genes that had ≥ |2|-fold change were identified as significantly differentially expressed. Differentially
regulated genes were clustered using SAS (ShanghaiBio Analysis System) to identify significant gene expression patterns in spleens (A) and
brains (B) of JEV-infected mice. Red indicates higher expression and green indicates lower expression in JEV-infected mice versus control. Black
indicates no expression difference. The small figure represents color scales used in the cluster map.C indicates control group and V indicates
viral-inoculated group. Each group contains 3 mice.
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Figure 2 Enriched Gene Ontology terms in the biological process category among differentially expressed genes.A f t e rm R N A
microarray assay, significantly enriched Gene Ontology analysis in the biological process category among differentially expressed genes (fold
change ≥ 2.0) in spleens (A) and brains (B) of JEV-infected mice was performed by using SAS (ShanghaiBio Analysis System). Each color section
represents a different biological process and the gene number enriched in this section was shown following the biological process name.
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microarray data.
Discussion
Spleen is one of the major peripheral immunity organs
and CNS is the ultimate infection target of JEV.
Therefore, identification of the JEV-related host genes in
spleens and brains of mice infected with JEV may be
helpful for understanding of JEV pathogenesis. To this
end, profiles of mRNA expression in both spleen and
brain tissues of JEV-infected mice were analyzed system-
atically in this study.
In mRNA profiling assay, we found chemokines like
CCL2 and CXCL10 were significantly up-regulated in
both mouse spleen and brain in response to JEV-infec-
tion, suggesting a strong inflammatory response of host.
Monocyte chemoattractant protein-1 (MCP-1/CCL2) is
one of the key chemokines that regulate migration and
infiltration of monocytes/macrophages. It was involved
in neurological disorders such as encephalitis-related
neuronal death, where its levels were elevated in astro-
cytes leading to neuronal death [13]. Previous study has
demonstrated that the WNV-infection stimulated the
expression of CCL2 in mice livers, suggesting a consis-
tent result to our study of JEV [10]. CXCL10 is also
found to play a crucial role in the host defense response
against various viral infection of the CNS by enhancing
innate immune responses [14,15], and our result of up-
regulated CXCL10 mRNA has a good agreement with
that was reported by Gupta et al. and Biswas et al.
[11,12].
In addition, a strong IFN-pathway-related response
was evident in mouse spleen and brain infected with
JEV, with increased expression of IFN-g, IFN response
transcription factor IRF7, IFN-induced proteins IFIT1,
IFITM3 and IFITM7 in spleen, and IRF7, IFN-inducible
transcription factors STAT1 and STAT2, IFN-induced
proteins IFIT1, IFIT2 and IFIT3 in brain, implying the
occurrence of a protective response of host. Similar
results were shown in previous reports as the upregula-
tion of IFN-g, STAT1 and STAT2 in JEV-infected mice
brain [12], and increased expression of STAT1 and
IFIT3 in JEV-infected N2A cells [11]. The reason why
no increase in expression of IFN-g was found in brains
of JEV-infected mice in our study may be related to the
difference of time points with Biswas’ study [11]. IRF7 is
activated in the presence of double stranded RNA fol-
lowing virus infection, which is functional as one of the
regulators of the IFN-a/b gene promoter and the IFN-
a/b responsive genes to create an antiviral state [16].
The increased expression of IRF7 has also been demon-
strated in WNV infected mice, but wasn’tf o u n di nJ E V
infected cells [17,18]. This m a yb ed u et ot h ed i f f e r e n t
signal pathways between intact host and cell culture.
Pore-forming protein perforin and the family of gran-
zymes have been demonstrated to form an antiviral
arsenal central to the function of cytotoxic T lympho-
cyte (CTL) and natural killer (NK) cells [19-21]. After
JEV infection, pro-apoptotic genes found to have signifi-
cant enhancement in mouse spleen, including porferin,
Table 1 Significant pathways of the differential
expressed genes in spleens of JEV-infected mice
Pathway name No. of genes p-Value
Antigen processing and presentation 9 0
Chemokine signaling pathway 13 0
Complement and coagulation cascades 7 0
Cytokine-cytokine receptor interaction 23 0
Natural killer cell mediated cytotoxicity 9 0
Classical Complement Pathway 3 1.00E-04
Complement Pathway 3 4.00E-04
Alternative Complement Pathway 2 0.0021
Granzyme A mediated Apoptosis Pathway 2 0.0036
Toll-like receptor signaling pathway 4 0.0071
Intestinal immune network for IgA production 3 0.009
CCR3 signaling in Eosinophils 2 0.0111
Caspase Cascade in Apoptosis 2 0.0121
NOD-like receptor signaling pathway 3 0.0121
MAPK signaling pathway 6 0.0168
ECM-receptor interaction 3 0.0232
Jak-STAT signaling pathway 4 0.0284
IFN gamma signaling pathway 1 0.0478
B Lymphocyte Cell Surface Molecules 1 0.0611
T cell receptor signaling pathway 3 0.069
Table 2 Significant pathways of the differential
expressed genes in brains of JEV-infected mice
Pathway name No. of genes p-value
Chemokine signaling pathway 19 0
Cytokine-cytokine receptor interaction 30 0
Jak-STAT signaling pathway 19 0
MAPK signaling pathway 19 0
NOD-like receptor signaling pathway 10 0
Purine metabolism 14 0
Toll-like receptor signaling pathway 13 0
IL-2 Receptor Beta Chain in T cell Activation 5 6.00E-
04
Neuroactive ligand-receptor interaction 16 6.00E-
04
NF-kB activation by Nontypeable Hemophilus
influenzae
4 0.0012
Apoptosis 7 0.0023
Antigen processing and presentation 7 0.0037
IFN gamma signaling pathway 2 0.0082
Natural killer cell mediated cytotoxicity 8 0.011
T cell receptor signaling pathway 7 0.0123
IFN alpha signaling pathway 2 0.0156
FAS signaling pathway (CD95) 3 0.0173
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Genbank Accession Gene symbol Gene description Fold change p-Value
Up-regulated
NM_177261 Kndc1 kinase non-catalytic C-lobe domain (KIND) containing 1 21.440 0.0252
NM_019494 Cxcl11 chemokine (C-X-C motif) ligand 11 19.752 0.0084
NM_013542 Gzmb granzyme B 6.202 0.0286
NM_031167 Il1rn interleukin 1 receptor antagonist (Il1rn), transcript variant 1 6.060 0.0015
AK157531 LOC629091 activated spleen cDNA, RIKEN full-length enriched library, clone:F830221E13 5.500 0.0154
NM_001033228 Itga1 integrin alpha 1 5.482 0.0308
NM_013584 Lifr leukemia inhibitory factor receptor 5.319 0.0109
NM_177923 H2-M10.2 histocompatibility 2, M region locus 10.2 5.276 0.0009
NM_008198 Cfb complement factor B 5.188 0.0019
NM_001005858 LOC667370 similar to interferon-induced protein with tetratricopeptide repeats 3 4.949 0.0459
NM_145153 Oas1f 2’-5’ oligoadenylate synthetase 1F 4.619 0.0013
NM_011331 Ccl12 chemokine (C-C motif) ligand 12 4.539 0.0308
NM_027893 Pvrl4 poliovirus receptor-related 4 4.429 0.0352
NM_010741 Ly6c lymphocyte antigen 6 complex, locus C 4.287 0.0042
NM_010370 Gzma granzyme A 4.236 0.0010
NM_009152 Sema3a sema domain, immunoglobulin domain (Ig), short basic domain, secreted,
(semaphorin) 3A
4.132 0.0358
AF229257 Usp29 ubiquitin-specific processing protease 29 4.033 0.0093
NM_133871 Ifi44 interferon-induced protein 44 3.843 0.0053
NM_009912 Ccr1 chemokine (C-C motif) receptor 1 3.734 0.0013
BC025535 Fcgr1 Fc receptor, IgG, high affinity I 3.668 0.0096
NM_145226 Oas3 2’-5’ oligoadenylate synthetase 3 3.531 0.0017
NM_008331 Ifit1 interferon-induced protein with tetratricopeptide repeats 1 3.433 0.0460
NM_021274 Cxcl10 chemokine (C-X-C motif) ligand 10 3.418 0.0307
NM_016850 Irf7 interferon regulatory factor 7 3.378 0.0083
NM_008530 Ly6f lymphocyte antigen 6 complex, locus F 3.313 0.0027
NM_011940 Ifi202b interferon activated gene 202B 3.296 0.0266
NM_145211 Oas1a 2’-5’ oligoadenylate synthetase 1A 3.283 0.0082
NM_145227 Oas2 2’-5’ oligoadenylate synthetase 2 3.178 0.0083
NM_144559 Fcgr4 Fc receptor, IgG, low affinity IV 3.069 0.0067
NM_027835 Ifih1 interferon induced with helicase C domain 1 2.940 0.0258
NM_008462 Klra2 killer cell lectin-like receptor, subfamily A, member 2 2.906 0.0001
NM_021792 Iigp1 interferon inducible GTPase 1 2.535 0.0232
L38281 Irg1 immune-responsive gene 1 2.496 0.0329
NM_008329 Ifi204 interferon activated gene 204 2.422 0.0290
NM_025378 Ifitm3 interferon induced transmembrane protein 3 2.401 0.0002
NM_021378 Klrc3 killer cell lectin-like receptor subfamily C, member 3 2.396 0.0063
NM_011909 Usp18 ubiquitin specific peptidase 18 2.333 0.0473
NM_011333 Ccl2 chemokine (C-C motif) ligand 2 2.314 0.0356
NM_028968 Ifitm7 interferon induced transmembrane protein 7 2.246 0.0014
NM_008337 Ifng interferon gamma 2.229 0.0054
NM_011338 Ccl9 chemokine (C-C motif) ligand 9 2.155 0.0065
NM_010653 Klrc2 killer cell lectin-like receptor subfamily C, member 2 2.131 0.0076
NM_009909 Il8rb interleukin 8 receptor, beta 2.077 0.0036
NM_010555 Il1r2 interleukin 1 receptor, type II 2.069 0.0248
NM_010652 Klrc1 killer cell lectin-like receptor subfamily C, member 1 2.025 0.0125
NM_011073 Prf1 perforin 1 (pore forming protein) 1.820 0.0326
NM_010722 Lmnb2 lamin B2 1.381 0.1976
Down-regulated
NM_025989 Gp2 glycoprotein 2 (zymogen granule membrane) 0.048 0.0005
NM_053094 Cd163 CD163 antigen 0.060 0.0171
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cytotoxic response against JEV infection. The consistent
result as increased expression of granzyme A and B was
also shown in the report about WNV infection [17].
Granzyme B is the most characterized granyzme which
plays an important role in inducing apoptosis, and it is
generally accepted that granzyme A can trigger a dis-
tinct nonapoptotic form of cell death [22]. The high
expression of granzyme A and B in spleen could help
clear virus infection, but may also involve lymphocyte
injury. The upregulation of apoptosis-related proteins
Caspase3 and 4 were also detected in brains of mice
infected with JEV, indicating an inflammation-related
neuronal apoptosis. Caspase 3 is an effector caspase that
function as a central regulator of apoptosis. It has been
reported that JEV infection triggers apoptosis in differ-
ent cells, such as baby hamster kidney BHK-21 cells,
mouse neuroblastoma N18 cells, human neuronal NT-2
cells, and human medulloblastoma cells, resulting in
caspase 3 activation [23-25]. The function of caspase 4
is not fully known, but it is believed to be an inflamma-
tory caspase, with a role in the immune system [26].
Pro-inflammatory cytokines like IL-1 and IL-6 were
found to have increased expression in the brain, which
was consistent with the results of the studies on DV and
WNV [8,17]. IL-1a and IL-1b has been known to form
an important part of the inflammatory response of the
body against infection. IL-6 together with IL-1 and
TNF-a acts as an endogenous pyrogen by causing fever
following viral infections [27]. It’s also associated with
an unfavorable outcome following yellow fever virus
infection [28]. Evidence suggests that circulating IL-6
can activate CNS mechanisms resulting in the develop-
ment of the febrile response during disease [29]. Upre-
gulation of IL-1 and IL-6 in brain may thus be
protective against harmful JEV infection, but also have a
pathogenic role in CNS.
The 2’,5 ’-oligoadenylate synthetase (OAS) and its
downstream effector RNase L play important roles in
host defense against virus infection. The OAS1b protein
has been described as a flavivirus resistance factor, and
OASl1 as a WNV-resistance factor in wild mice because
a truncated version of the protein is expressed in labora-
tory mice which are susceptible to infection [30-32].
Human OAS1 p42/p46 and OAS3 p100 are likely to
contribute to host defense against DEN infection and
play a role in determining the outcomes of DEN disease
severity [33]. Further, the activated expression of OAS2
has been demonstrated in mouse brain in response to
JEV infection [34]. In present study, there was increased
Table 3 Differentially-regulated genes of our interest in spleens of mice with JEV Infection (Continued)
NM_177261 Kndc1 kinase non-catalytic C-lobe domain (KIND) containing 1 0.085 0.0070
NM_144943 Cd207 CD 207 antigen 0.159 0.0441
NM_010378 H2-Aa histocompatibility 2, class II antigen A, alpha 0.184 0.0055
NM_028135 Tmem163 transmembrane protein 163 0.211 0.0196
NM_007720 Ccr8 chemokine (C-C motif) receptor 8 0.242 0.0150
NM_016851 Irf6 interferon regulatory factor 6 0.261 0.0037
NM_013509 Eno2 enolase 2, gamma neuronal (Eno2) 0.276 0.0234
NM_011780 Adam23 a disintegrin and metallopeptidase domain 23 (Adam23) 0.281 0.0009
U96752 H2-Q1 major histocompability complex Q1b 0.282 0.0247
NM_008341 Igfbp1 insulin-like growth factor binding protein 1 0.289 0.0144
NM_010565 Inhbc inhibin beta-C (Inhbc) 0.304 0.0307
AK089361 AK089361 B6-derived CD11 +ve dendritic cells cDNA 0.307 0.0417
NM_013517 Fcer2a Fc receptor, IgE, low affinity II, alpha polypeptide 0.315 0.0318
NM_016808 Usp2 ubiquitin specific peptidase 2 (Usp2), transcript variant 1 0.319 0.0266
AK041838 Il7r interleukin 7 receptor 0.319 0.0256
NM_001033126 Cd27 CD antigen 27 (Cd27), transcript variant 1 0.326 0.0158
NM_009142 Cx3cl1 chemokine (C-X3-C motif) ligand 1 0.343 0.0227
NM_010215 Il4i1 interleukin 4 induced 1 0.387 0.0129
NM_207105 H2-Ab1 histocompatibility 2, class II antigen A, beta 1 0.520 0.0255
NM_033217 Ngfr nerve growth factor receptor (TNFR superfamily, member 16) 0.440 0.0110
AK041345 Xlr4a X-linked lymphocyte-regulated 4A 0.460 0.0074
NM_033042 Tnfrsf25 tumor necrosis factor receptor superfamily, member 25 0.465 0.0366
NM_198297 Trat1 T cell receptor associated transmembrane adaptor 1 0.476 0.0334
NM_011161 Mapk11 mitogen-activated protein kinase 11 0.478 0.0128
NM_007549 Blk B lymphoid kinase 0.483 0.0103
NM_010818 Cd200 Cd200 antigen 0.494 0.0156
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Genbank
Accession
Gene symbol Gene description Fold
change
p-Value
Up-regulated
NM_021274 Cxcl10 chemokine (C-X-C motif) ligand 10 1760.024 0.0020
NM_011333 Ccl2 chemokine (C-C motif) ligand 2 1387.794 0.0320
NM_013652 Ccl4 chemokine (C-C motif) ligand 4 336.804 0.0151
NM_010846 Mx1 myxovirus (influenza virus) resistance 1 229.188 0.0136
NM_145209 Oasl1 2’-5’ oligoadenylate synthetase-like 1 209.863 0.0242
NM_011940 Ifi202b interferon activated gene 202B 201.477 0.0317
NM_008329 Ifi204 interferon activated gene 204 165.395 0.0404
NM_021792 Iigp1 interferon inducible GTPase 1 159.817 0.0168
NM_011337 Ccl3 chemokine (C-C motif) ligand 3 111.943 0.0429
NM_008176 Cxcl1 chemokine (C-X-C motif) ligand 1 107.659 0.0158
AK085407 Ifi44 interferon gamma inducible protein 44 91.009 0.0062
NM_010555 Il1r2 interleukin 1 receptor, type II 89.273 0.0297
NM_021893 Cd274 CD274 antigen 87.250 0.0337
NM_008330 Ifi47 interferon gamma inducible protein 47 83.552 0.0286
NM_172648 Ifi205 interferon activated gene 205 82.479 0.0416
NM_194336 Mpa2l macrophage activation 2 like 77.279 0.0464
NM_007609 Casp4 caspase 4, apoptosis-related cysteine peptidase 77.077 0.0451
NM_017466 Ccrl2 chemokine (C-C motif) receptor-like 2 74.783 0.0071
NM_008332 Ifit2 interferon-induced protein with tetratricopeptide repeats 2 65.247 0.0222
NM_011331 Ccl12 chemokine (C-C motif) ligand 12 65.192 0.0079
NM_033601 Bcl3 B-cell leukemia/lymphoma 3 53.003 0.0138
NM_029803 Ifi27 interferon, alpha-inducible protein 27 47.264 0.0403
NM_031168 Il6 interleukin 6 44.884 0.0106
NM_016850 Irf7 interferon regulatory factor 7 42.752 0.0463
NM_145211 Oas1a 2’-5’ oligoadenylate synthetase 1A 41.831 0.0497
NM_011909 Usp18 ubiquitin specific peptidase 18 40.804 0.0052
NM_010501 Ifit3 interferon-induced protein with tetratricopeptide repeats 3 39.282 0.0008
NM_007707 Socs3 suppressor of cytokine signaling 3 36.912 0.0087
NM_008331 Ifit1 interferon-induced protein with tetratricopeptide repeats 1 32.115 0.0013
NM_013606 Mx2 myxovirus (influenza virus) resistance 2 31.018 0.0003
NM_011854 Oasl2 2’-5’ oligoadenylate synthetase-like 2 29.655 0.0131
NM_009896 Socs1 suppressor of cytokine signaling 1 28.609 0.0492
NM_009140 Cxcl2 chemokine (C-X-C motif) ligand 2 24.678 0.0392
NM_010397 H2-T22 histocompatibility 2, T region locus 22 21.010 0.0473
NM_027835 Ifih1 interferon induced with helicase C domain 1 19.804 0.0233
NM_009397 Tnfaip3 tumor necrosis factor, alpha-induced protein 3 19.385 0.0300
NM_009283 Stat1 signal transducer and activator of transcription 1 18.134 0.0348
NM_001083925 Oas1b 2’-5’ oligoadenylate synthetase 1B 17.574 0.0342
NM_008361 Il1b interleukin 1 beta 15.753 0.0043
NM_133211 Tlr7 toll-like receptor 7 9.880 0.0343
NM_027450 Glipr2 GLI pathogenesis-related 2 9.275 0.0405
NM_008562 Mcl1 myeloid cell leukemia sequence 1 9.054 0.0336
NM_029419 Apol3 apolipoprotein L 3 8.806 0.0165
NM_001008700 Il4ra interleukin 4 receptor, alpha 8.639 0.0360
NM_013730 Slamf1 signaling lymphocytic activation molecule family member 1 8.274 0.0435
NM_009841 Cd14 CD14 antigen 6.666 0.0034
NM_033541 Oas1c 2’-5’ oligoadenylate synthetase 1C 6.596 0.0120
NM_009810 Casp3 caspase 3, apoptosis-related cysteine peptidase 2.119 0.0117
Down-regulated
NM_053094 Cd163 CD163 antigen 0.066 0.0007
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brains of JEV-infected mice, including OAS1a, OAS1b,
OAS1c, OAS1e, and OAS2. Therefore, the ability of
these proteins to protect against JEV infection should
also be further studied.
The significant downregulation of CD163 was detected
both in mouse spleen and brain in response to JEV infec-
tion. CD163 is a novo identified marker for perivascular
macrophages in humans, monkeys, and mice. And
previously studies have found that perivascular CD163
expression is upregulated and the number of CD163-posi-
tive cells increases in HIV and SIV encephalitis (HIVE and
SIVE) brains [35,36]. However, CD163 is not a “classical”
activation marker, because peripheral blood monocytes
and most tissues macrophages of normal uninfected con-
trols all express it and because in vitro pro-inflammatory
stimuli largely down-regulate its expression. These find-
ings suggest that CD163 expression is regulated in
Table 4 Differentially-regulated genes of our interest in brains of mice with JEV Infection (Continued)
XM_898059 Cd209f CD209f antigen 0.088 0.0271
NM_026972 Cd209b CD209b antigen 0.132 0.0149
NM_033042 Tnfrsf25 tumor necrosis factor receptor superfamily, member 25 0.196 0.0288
NM_016708 Npy5r neuropeptide Y receptor Y5 (Npy5r) 0.242 0.0351
NM_019577 Ccl24 chemokine (C-C motif) ligand 24 (Ccl24) 0.302 0.0132
NM_008409 Itm2a integral membrane protein 2A 0.302 0.0075
AK042749 D230046B21Rik 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:
A730020N04
0.311 0.0358
NM_030143 Ddit4l DNA-damage-inducible transcript 4-like 0.318 0.0004
NM_022723 Scube1 signal peptide, CUB domain, EGF-like 1 0.319 0.0400
AK144387 4732444A12Rik 21 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:
G630051C23
0.319 0.0000
AK082652 Tmem44 transmembrane protein 44 0.324 0.0108
NM_175106 Tmem177 transmembrane protein 177 (Tmem177) 0.330 0.0346
NM_175564 Tmem169 transmembrane protein 169 0.336 0.0371
NM_027016 Tloc1 translocation protein 1 0.336 0.0276
NM_027163 Il1f8 interleukin 1 family, member 8 0.421 0.0267
NM_022986 Irak1bp1 interleukin-1 receptor-associated kinase 1 binding protein 1 0.422 0.0169
NM_016851 Irf6 interferon regulatory factor 6 0.447 0.0303
NM_145826 Il17re interleukin 17 receptor E (Il17re), transcript variant 1 0.477 0.0403
Table 5 Comparison of expression changes of some selected genes between microarray and qRT-PCR
Gene name Gene description Fold change
Microarray qRT-PCR
Spleen
Cxcl10 chemokine (C-X-C motif) ligand 10 3.418 3.375 (±1.065)
Ifng interferon gamma 2.229 3.062 (±0.507)
Gzmb granzyme B 6.202 7.285 (±0.311)
Gzma granzyme A 4.236 3.815 (±0.127)
Prf1 Porferin 1 1.820 2.287 (±0.643)
Irf7 interferon regulatory factor 7 3.378 4.926 (±0.309)
Il1r2 Interleukin 1 receptor, type II 2.069 2.078 (±0.105)
Cd163 CD163 antigen 0.060 0.083 (±0.017)
Brain
Cxcl10 chemokine (C-X-C motif) ligand 10 1760.024 13.492 (±1.690)
Ccl2 chemokine (C-C motif) ligand 2 1387.794 188.549 (±8.931)
Ccl4 chemokine (C-C motif) ligand 4 336.804 61.007 (±3.735)
Casp3 Caspase3, apoptosis-related cysteine peptidase 2.119 1.207 (±0.073)
Casp4 caspase4, apoptosis-related cysteine peptidase 77.077 19.969 (±0.050)
Socs1 suppressor of cytokine signaling 1 28.609 11.182 (±0.845)
Socs3 suppressor of cytokine signaling 3 36.912 4.672 (±0.464)
Cd163 CD163 antigen 0.066 0.065 (±0.012)
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Page 9 of 11association with a certain stage of differentiation. Here,
our results showed a downregulated CD163 mRNA level
in response to acute JEV infection, which probably sug-
gested a decreased number of activated perivascular
macrophages resulted by inflammatory disorder-related
apoptosis response.
Conclusions
In summary, our findings suggested that JEV infection
resulted in significant changes in the expression of mul-
tiple genes in mouse spleen and brain, including inflam-
matory cytokines, chemokines, IFN inducible genes, IFN
regulators, and apoptosis related genes, etc. These genes
m a yp l a yac r i t i c a lr o l eo na n t i v i r a lr e s p o n s eo fh o s t
against JEV infection but could also contribute to the
pathogenesis of JEV resulting in encephalitis. The
mRNA profile obtained by microarray analysis in this
study may provide a foundation for future investigation
of JEV pathogenesis and therapeutic method.
Methods
Virus production
JEV wide type strain P3 was propagated in brains of
suckling mice and titered in BHK-21 cells which was
grown and maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% heated-
inactivated fetal bovine serum (FBS, Hyclone, Logan,
UT, USA), 100 g/ml streptomycin and 100 IU/ml peni-
cillin (Sigma-Aldrich, MO, USA) at 37°C with 5% CO2.
Virus infection of mice
Four-weeks-old naive female BALB/c mice were pur-
chased from Wuhan Institute of Biologic Products (Hubei
Province, China) and inoculated subcutaneously (s.c.) with
5×1 0
6 PFU of JEV P3 strain. Dilutions were performed in
serum-free DMED and experimental controls were mock
injected with diluent. A part of JEV-infected mice were
sacrificed at day 3 post-inoculation (the day before the
neurological symptoms appeared), and spleens were har-
vested. The left mice were sacrificed at day 6 post-inocula-
tion (the day before the mice started to die), and brains of
mice were harvested. Spleen and brain homogenate was
made in DMEM for RNA extraction.
Microarrays and bioinformatics
The total RNA was isolated from mouse spleens and
brains respectively with trizol reagent (Invitrogen) for
mRNA Microarray. mRNA hybridization was performed
by shanghaiBio Corporation (shanghai, China) with the
use of 4 × 44 K Agilent Whole Mouse Genome Oligo
Microarray (total 41,174 oligo probes from 41,174 mouse
genes). For each sample pair, the experiments were done
with two independent hybridizations (Cy3 and Cy5 inter-
changing labeling). Hybridized arrays were scanned at
5 μm resolution on an Agilent DNA Microarray Scanner
(Model G2565BA). Data extraction from images was
done by using Agilent Feature Extraction software. Hier-
archical cluster, gene ontology and pathway analysis were
analyzed by using SAS (ShanghaiBio Analysis System).
Quantitative real-time RT-PCR (RT-qPCR)
For selected mRNA RT-qPCR, total RNA from the same
samples used in microarray analysis was tested by using
ABI 7500 FAST real-time PCR system. PCR primers
were designed with Primer Express 2.0 software (Invitro-
gen). Results are shown as fold change. For mRNA
RT-qPCR, experiments were carried out with the Primer-
Script RT reagent Kit (TaKaRa) and SYBR Green Realtim
PCR Master Mix (TaKaRa) according to manufacture’s
instruction. The housekeeping gene GHDAP was used
for standardization of the initial RNA content of a sam-
ple. Relative changes of gene expression were calculated
by the following formula, and the data are represented as
fold upregulation/downregulation. fold change = 2
-ΔΔCt,
whereΔΔCt =(Ct of gene of interest, treated -Ct of HK
gene, treated)-(Ct of gene of interest, control-Ct of HK
gene, control), Ct is the threshold cycle number and HK
is the house keeping gene.
Statistical analysis
Each gene in each infection group was subjected to a
Student’s t test to detect large expression differences
relative to the mock-infected group. p-values <0.05 were
considered to be statistically significant.
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